Regulatory and Clinical Considerations in Peptide Therapeutics
Peptide therapeutics are regulated under pharmaceutical and biologic guidelines. Clinical development requires rigorous evaluation of pharmacology, safety, and efficacy. Early-phase trials focus on pharmacokinetics, dosing, and tolerability, while later phases assess clinical outcomes.
Ethical considerations, patient education, and monitoring are critical. Peptides often require specialized administration, and adherence can influence therapeutic success. Regulatory oversight ensures consistent manufacturing, quality control, and patient safety.
5 Views